Graft-versus-host disease

Graft-versus-host disease
Definition
Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body.

Graft-versus-host disease (GVHD) is a complication that can occur after a bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body.
See also: Transplant rejection
Overview, Causes, & Risk Factors ...

Term Definition
Graft-versus-host disease
A disease caused when cells from a donated stem cell graft attack the normal tissue of the transplant patient. Symptoms include jaundice, skin rash or blisters, a dry mouth, or dry eyes. Also called GVHD.

Graft-versus-Host Disease (GvHD)
Graft-versus-host disease is a reaction of the T-lymphocytes in the donor marrow (the graft), against the recipient's body (the host). GvHD can be acute or chronic.

Graft-Versus-Host Disease
GVHD is a common complication for people who get stem cells from a donor. In GVHD, the new stem cells attack your body.

Graft-versus-host disease: A reaction of donated bone marrow against a patient's own tissue. Also called GVHD.
Granulocyte (GRAN-yoo-lo-site): A type of white blood cell. Neutrophils, eosinophils, and basophils are granulocytes.

Graft-versus-host disease
A condition that occurs after tissue transplantation in which the donor-derived T cells attack the host's tissues.

graft-versus-host disease (GVHD) - when the donor�s immune system acts against the recipient�s tissue, after transplantation.

Graft-versus-host disease (GVHD) - a condition that occurs when the donor's immune system acts against the recipient's tissue after stem cell or bone marrow transplantation.

graft-versus-host disease
Graft-versus-host disease (GVHD) can be a serious and life-threatening complication of a bone marrow transplant. GVHD occurs when the donor's immune system reacts against the recipient's tissue.

Graft-versus-host disease (GVHD)
Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation in which the transplanted marrow recognise the recipient as "foreign" and mount an immunologic attack.

Graft-versus-Host Disease
Patients who have received allogeneic or matched unrelated transplants are at risk for graft-versus-host disease (GVHD).

Graft-Versus-Host Disease and Graft Failure
Donated stem cells can attack your body. This is called graft-versus-host disease. Your immune system also can attack the donated stem cells. This is called graft failure.

Graft-versus-host disease (GVHD): A complication of bone marrow transplants in which T cells in the donor bone marrow graft go on the offensive and attack the host's tissues.

Graft-versus-host disease (GVHD) is a serious attack by the patient's immune system triggered by the donated new marrow in allogeneic transplants. Acute GVHD occurs in over half of allogeneic transplants, usually within 90 days.

Graft-versus-host disease. The new cells may destroy other cells in your body. They most commonly attack the skin, liver, and digestive system. This happens less often when umbilical cord stem cells are used.

graft-versus-host disease (GVHD) - the condition that results when the immune cells of a transplant (usually of bone marrow) from a donor attack the tissues of the person receiving the transplant.

Graft-versus-host disease (GVHD) is a major complication of allogeneic transplantation, and the intestinal tract, skin, and liver are commonly affected.

Acute graft-versus-host disease
Allogeneic hematopoietic cell transplantation
Autologous hematopoietic cell transplantation
Chronic graft-versus-host disease
Graft-versus-host disease
Hematopoietic cell transplantation ...

GVHD: Graft-versus-host disease.
Search All of MedicineNet For:
Treat Osteoarthritis (OA) Pain Where
It Hurts ...

beclomethasone (beh-kloh-MEH-thuh-sone) A drug being studied in the treatment of graft-versus-host disease. It belongs to a family of drugs called corticosteroids.
Permalink for beclomethasone ...

Infection, inflammation of the airway, fluid overload, graft-versus-host disease, and bleeding are all potential life-threatening complications that may occur in the lungs and pulmonary system.
organ damage ...

This has led to the concept of an immunologic graft-versus-leukemia effect, similar to (and related to) graft-versus-host disease.

Bile duct paucity in Graft-Versus-Host Disease ... pale stool
Bile duct paucity in Liver Allograft Rejection ... pale stool
Bile duct paucity, non syndromic form ... pale stool
Biliary Atresia ...

When you receive cells from another person, a complication known as graft-versus-host disease (GVHD) sometimes develops. GVHD occurs when white blood cells from the donor attack your cells.

Dealkylations, Detachments, Posterior Vitreous, Difenin, Dihydropteroate Synthetase, Diseases, Neurologic Autoimmune, Ditiocarb, Zinc Salt, Forneau 933, Frequencies, Allele, Ganglion, Stellate, Graft-Versus-Host Disease, Health, Mental, Hemeproteins, ...

In an ALLO transplant, another major risk is that the donor's cells will recognize the patient's body as foreign, causing graft-versus-host disease (GVHD). GVHD may be a serious complication of allogeneic transplants and can be fatal.

Bone marrow transplant from a matched volunteer donor or a partially matched family donor carries a greater risk of graft failure or severe graft-versus-host disease.

Also under study is a novel method for preventing graft-versus-host disease, a serious complication that occurs when transplanted cells don’t recognize the tissues and organs of the recipient's body and react against the recipient' ...

In addition, graft-versus-host disease (GVHD) may occur in patients who receive bone marrow from a donor. In GVHD, the donated marrow attacks the patient's tissues (most often the liver, the skin, and the digestive tract).

Patients who are experiencing diarrhea due to graft-versus-host disease will continue to take their immunosuppressant drugs. They may also be treated with corticosteroids and antidiarrheal medications.
Alternative and complementary therapies ...

Transplant rejection is when a transplant recipient's immune system attacks a transplanted organ or tissue. See also graft-versus-host disease.
Alternative Names
Graft rejection; Tissue/organ rejection ...

Graft-versus-host disease
Lacrimal gland tumor
Hypoventilation
Aminophylline overdose
Pine oil poisoning
Laxative overdose
Simple pulmonary eosinophilia
Esophageal stricture - benign
Exercise and stress reduction
Fair skin cancer risks ...

Itching can occur as chronic side effect of anti-cancer treatments including Proleukin® (Interleukin-2), Interferon (Intron®& Roferon®), radiation therapy, acute and chronic graft-versus-host disease (GVHD), ...

Recombinant human KGF (rHuKGF) is being studied in the prevention of graft-versus-host disease (GVHD) that may occur after tissue transplantation, and in the treatment of mucositis caused by chemotherapy and radiation therapy.

Blood transfusions are always irradiated to remove white blood cells and thereby reduce the risk of graft-versus-host disease. Patients may also receive a hormone to stimulate production of red blood cells.

Graft-versus-host disease: This is when your donor's cells attack your own body. In the first few months after the transplant, symptoms may be a skin rash, diarrhea, or abnormal liver tests.

After the procedure, there's a risk that the new stem cells will react against your body's healthy tissues, causing potentially fatal damage (graft-versus-host disease).

bone marrow and/or stem cell transplantation is recommended specialists in Jefferson's transplant program are pioneering efforts to reduce complications of transplant procedures, such as a potentially fatal reaction called graft-versus-host disease ...

Oral squamous cell carcinoma may develop in patients with Fanconi anemia, dyskeratosis congenita (a rare bone marrow failure syndrome), chronic graft-versus-host disease, epidermolysis bullosa, xeroderma pigmentosum, ...

Lichenoid eruptions can occur in graft-versus-host disease in people who have received bone marrow transplants.

The medicines used to prepare the body can cause unpleasant side effects and there is a risk of complications, such as your body rejecting the new stem cells, the new stem cells attacking your body (known as graft-versus-host disease) and infection.

Parental marrow can now be used successfully after it's depleted of T cells, which could cause fatal acute graft-versus-host disease. T cells are removed with monoclonal antibodies or lectin columns. Immunoglobulin may be given I.V.

Chemotherapy and radiation therapy cause nausea, vomiting, diarrhea, bone marrow suppression, and immunosuppression. BMT carries an additional risk of early death due to complications, including graft-versus-host disease.

lines, giving the patient a new immune system, red blood cells, and platelets. However, besides the risk of graft failure, there is also a risk that the newly created white blood cells may attack the rest of the body (\"graft-versus-host disease\").

spinal cord (myelitis), eye (retinitis), or other organs such as the lungs (pneumonia) or intestinal gract (gastritis, enteritis, or colitis). In addition, transplant recipients may develop organ rejection or graft-versus-host disease associated with ...

See also: Cancer, Symptom, Infections, Leukemia, Bone marrow transplant